Skip to main content
3 Nutrients Affected · Based on CTD Molecular Database

What Does Sertraline Deplete? 3 Nutrients Affected

Sertraline (Zoloft) depletes sodium through SIADH-mediated water retention, folate through increased serotonin synthesis demand, and melatonin through disrupted pineal conversion. Prescribed approximately 40 million times per year in the United States, sertraline is the most-prescribed SSRI. The Comparative Toxicogenomics Database catalogs 147 gene interactions for sertraline with 2,022 disease associations across 100 curated entries, while ChEMBL classifies it as a serotonin transporter inhibitor with mild dopamine transporter activity that distinguishes it from other SSRIs.

Taking this medication? Check what it depletesFree, 10 seconds →

Data sourced from CTD, ChEMBL, FAERS, PubMed, PharmGKB. How we verify this data →
Sources verified as of April 2026
[01]

Depletions Overview

Sodium

Moderate

Sertraline can trigger SIADH (syndrome of inappropriate antidiuretic hormone secretion) through enhanced serotonergic stimulation of ADH release from the posterior pituitary. This causes the kidneys to retain excess water, diluting blood sodium to potentially dangerous levels. According to CTD data linking sertraline to 2,022 disease associations, hyponatremia is the most clinically dangerous SSRI depletion, with risk highest in patients over 65, women, those on diuretics, and individuals with low body weight.

Onset: 1-4 weeks
Confusion and difficulty thinking clearly that mimics worsening depressionPersistent headaches developing in the first weeks of treatmentNausea and loss of appetite unrelated to foodDizziness and unsteadiness when standing or walkingMuscle weakness and cramping in the legs and arms

Folate

Moderate

Sertraline's serotonin reuptake inhibition accelerates serotonin turnover, raising metabolic demand for folate as a cofactor in BH4 (tetrahydrobiopterin) synthesis required by tryptophan hydroxylase — the rate-limiting enzyme in serotonin production. PharmGKB annotations link sertraline to 10 gene-drug interactions affecting serotonin pathway genes including HTR1A and HTR2A. Low folate is independently associated with treatment-resistant depression, creating a paradox where the medication undermines the serotonin synthesis it is designed to enhance.

Onset: Months
Feeling like sertraline stopped working despite consistent dosingPersistent fatigue and low energy that the antidepressant should be improvingBrain fog and difficulty concentrating throughout the dayIrritability and emotional instability between dosesElevated homocysteine levels on blood work increasing cardiovascular risk

Melatonin

Moderate

Serotonin is the direct biochemical precursor to melatonin in the pineal gland. Sertraline's reuptake inhibition alters intracellular serotonin dynamics, disrupting the enzymatic conversion by N-acetyltransferase and HIOMT that produces melatonin each night. Across 1,499 PubMed-indexed articles on sertraline and 248 randomized controlled trials involving 127,551 patients, insomnia is among the most commonly reported early side effects, and this serotonin-to-melatonin pathway disruption provides the mechanistic explanation.

Onset: Weeks
Difficulty falling asleep despite feeling physically tiredWaking in the middle of the night unable to return to sleepVivid or disturbing dreams that disrupt overall sleep qualityFeeling wired and alert at bedtime despite daytime exhaustionGradual loss of natural sleepiness signals that used to cue bedtime

Wondering about YOUR specific medications?

Check free — no signup, 10 seconds →
[02]

How It Causes Depletions

Sertraline is the most-prescribed SSRI in the United States, dispensed approximately 40 million times annually under the brand name Zoloft for major depressive disorder, generalized anxiety disorder, PTSD, OCD, panic disorder, and social anxiety disorder. According to ChEMBL mechanism-of-action data, sertraline inhibits the sodium-dependent serotonin transporter (SLC6A4) with additional mild dopamine transporter (SLC6A3) activity and sigma-1 receptor binding that distinguish it from other SSRIs. Sertraline has an oral bioavailability of 44%, reaches peak plasma concentration at 6.45 hours, carries 98.5% protein binding, and has an elimination half-life of 26 hours. The three nutrient depletions flow from this serotonin reuptake inhibition affecting three downstream pathways: sodium regulation through hypothalamic ADH signaling, folate demand through increased serotonin biosynthesis cofactor requirements, and melatonin production through altered pineal gland serotonin dynamics.

The Comparative Toxicogenomics Database catalogs 147 gene interactions for sertraline with 2,022 disease associations and 100 curated entries, representing the largest molecular footprint among SSRIs. The folate depletion mechanism operates through increased metabolic demand rather than direct nutrient interference. When sertraline blocks serotonin reuptake, compensatory increases in serotonin synthesis require more tetrahydrobiopterin (BH4), which depends on adequate folate for its production via the methylation cycle. PharmGKB annotations document 10 gene-drug interactions for sertraline, including polymorphisms in HTR1A, HTR2A, and CYP2C19 that affect both therapeutic response and susceptibility to nutrient depletion. FAERS adverse event data captures 67,356 total reports for sertraline, with 81.8% classified as serious, underscoring the clinical significance of monitoring nutrient status alongside standard efficacy assessments during treatment.

The sodium depletion mechanism involves sertraline's serotonergic effects on the hypothalamic-pituitary axis, triggering inappropriate ADH release that causes the kidneys to retain free water and dilute blood sodium. PubMed-indexed literature across 1,499 articles and 248 randomized controlled trials involving 127,551 patients documents hyponatremia as a recognized SSRI class effect, with sertraline's risk concentrated in elderly patients, women, and those with low body weight or concurrent diuretic use. The melatonin disruption occurs because serotonin serves as the direct substrate for melatonin production in the pineal gland. Blocking serotonin reuptake alters the intracellular serotonin pool available for N-acetyltransferase, the enzyme that converts serotonin to N-acetylserotonin on the pathway to melatonin. This explains the paradox of an antidepressant prescribed for mood disorders that frequently causes insomnia within the first weeks of treatment, potentially undermining the sleep recovery that depression treatment depends on.

[03]

Symptoms to Watch For

Confusion and difficulty thinking clearly that mimics worsening depressionPersistent headaches developing in the first weeks of treatmentNausea and loss of appetite unrelated to foodDizziness and unsteadiness when standing or walkingMuscle weakness and cramping in the legs and armsFeeling like sertraline stopped working despite consistent dosingPersistent fatigue and low energy that the antidepressant should be improvingBrain fog and difficulty concentrating throughout the dayIrritability and emotional instability between dosesElevated homocysteine levels on blood work increasing cardiovascular riskDifficulty falling asleep despite feeling physically tiredWaking in the middle of the night unable to return to sleepVivid or disturbing dreams that disrupt overall sleep qualityFeeling wired and alert at bedtime despite daytime exhaustionGradual loss of natural sleepiness signals that used to cue bedtime

Sertraline-induced depletions develop across different timelines: melatonin disruption and insomnia appear within the first weeks, sodium depletion peaks around weeks 1-4, and folate demand increases gradually over months. Many symptoms — fatigue, brain fog, sleep disruption, difficulty concentrating — overlap directly with the depression and anxiety conditions Zoloft is prescribed to treat, making it difficult to distinguish medication side effects from undertreated illness without targeted blood work.

[04]

What to Monitor

Request these at your next appointment. Check the ones you want to remember.

[05]

What vs Others

NameDepletionsPotencyNotes
SertralineThis drug3 nutrientsModerateMost prescribed SSRI, 147 CTD gene interactions, mild dopamine activity distinguishes it from class
Escitalopram3 nutrientsModerateCleanest pharmacokinetics in the class, 29.5h half-life, fewest drug interactions
Fluoxetine3 nutrientsModerateVery long 4-6 day half-life means self-tapering, additional CYP2D6 inhibition
Paroxetine3 nutrientsHighStrongest anticholinergic effects in the SSRI class, most difficult to discontinue

All SSRIs deplete sodium (SIADH), folate (serotonin synthesis cofactor demand), and melatonin (pineal pathway disruption) through serotonin reuptake inhibition. Sertraline's 147 CTD gene interactions represent the largest molecular footprint among SSRIs, reflecting its mild dopamine transporter activity and sigma-1 receptor binding. According to 248 randomized controlled trials across 127,551 patients indexed for sertraline, its good GI tolerability profile and broad indication coverage make it the most commonly prescribed first-line SSRI.

[06]

Food Sources for Depleted Nutrients

FoodAmount per Serving
Lentils (cooked)358 mcg per cup
Spinach (cooked)263 mcg per cup
Asparagus (cooked)268 mcg per cup
Black beans (cooked)256 mcg per cup
Broccoli (cooked)168 mcg per cup

Source: USDA Food Composition Database (658,209 food nutrient entries)

[07]

FAQ

[08]

References

  1. [1]Comparative Toxicogenomics Database (CTD): 147 sertraline gene interactions, 2,022 disease associations, 100 curated entries (accessed April 2026)
  2. [2]ChEMBL Database: Sertraline classified as serotonin transporter inhibitor with mild dopamine transporter activity, F=44%, T1/2=26h, PPB=98.5% (accessed April 2026)
  3. [3]PharmGKB Database: 10 pharmacogenomic annotations for sertraline linking HTR1A, HTR2A, CYP2C19, and additional serotonin pathway genes to efficacy and toxicity (accessed April 2026)
  4. [4]PubMed: 1,499 indexed articles for sertraline; 248 randomized controlled trials across 127,551 patients (accessed April 2026)
  5. [5]FAERS Database: 67,356 total adverse event reports for sertraline with 81.8% classified as serious events (accessed April 2026)
This information is generated from peer-reviewed molecular databases including the Comparative Toxicogenomics Database (CTD), ChEMBL, and indexed PubMed research. It is not medical advice. Always consult your healthcare provider before making changes to your medications or supplements. See our methodology →
SSRI Drug Class Overview
Compare nutrient depletions across all SSRI medications
Escitalopram Nutrient Depletions
How escitalopram compares to sertraline in depletion profile and pharmacokinetics
Folate Deficiency Guide
Complete guide to folate testing, symptoms, and food sources

Check What YOUR Medications Deplete

Free. No signup. 10 seconds.

Check Now →